Study Information

Title: A Phase 1, Open-label Trial of Oral Azacitidine (CC-486) Plus RCHOP in Subjects With Large B-Cell Lymphoma or Follicular Lymphoma or Transformed Lymphoma External
Status: Recruiting participants
Conditions: Lymphoma, Large B-Cell, Diffuse; Lymphoma, Follicular
Interventions: Drug: Oral Azacitidine; Drug: Rituximab; Drug: cyclophosphamide; Drug: Vincristine; Drug: Prednisone
Institutions: Dana-Farber Cancer Institute
Health Topics: Non-Hodgkin Lymphoma

Contact Information

Dana-Farber Cancer Institute
Boston, MA 02284